Literature DB >> 22677552

Mechanisms of renal disease in β-thalassemia.

Khaled M Musallam1, Ali T Taher.   

Abstract

Although advances in the care of patients with β-thalassemia translate into better patient survival, this success has allowed previously unrecognized complications to emerge, including several renal abnormalities. Clinical studies continue to show that mild tubular dysfunction and abnormalities in GFR are common in patients with β-thalassemia. Chronic anemia and iron overload are believed to lie behind these abnormalities. Nonprogressive increases in levels of serum creatinine have also been observed after exposure to some iron chelators. Longitudinal studies are needed to understand the true burden of renal dysfunction in patients with β-thalassemia.

Entities:  

Mesh:

Year:  2012        PMID: 22677552     DOI: 10.1681/ASN.2011111070

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

Review 1.  Renal complications of beta-thalassemia major in children.

Authors:  Ashraf Bakr; Youssef Al-Tonbary; Ghada Osman; Rasha El-Ashry
Journal:  Am J Blood Res       Date:  2014-09-05

2.  Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice.

Authors:  Monique P Gelderman; Jin Hyen Baek; Ayla Yalamanoglu; Michele Puglia; Florence Vallelian; Bo Burla; Jaroslav Vostal; Dominik J Schaer; Paul W Buehler
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941

3.  Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.

Authors:  Richard Coffey; Grace Jung; Joseph D Olivera; Gabriel Karin; Renata C Pereira; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

4.  Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.

Authors:  Chao-Hsiun Tang; Wesley Furnback; Bruce C M Wang; Jackson Tang; Derek Tang; Meng-Yao Lu; Vicky W-H Huang; Khaled M Musallam
Journal:  Transfusion       Date:  2021-09-10       Impact factor: 3.337

5.  Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia.

Authors:  Azza A G Tantawy; Nagham El Bablawy; Amira A M Adly; Fatma S E Ebeid
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

6.  Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients.

Authors:  Mozhgan Hashemieh; Mitra Radfar; Azita Azarkeivan; Seyed Mohammad Taghi Hosseini Tabatabaei; Sedigheh Nikbakht; Mehdi Yaseri; Kourosh Sheibani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

7.  Comparing different markers of tubular dysfunction in transfusion-dependent thalassemia patients.

Authors:  Ilham Youssry; Samuel Makar; Khalil Abdelkhalek; Dina Hisham; Happy Sawires
Journal:  Int Urol Nephrol       Date:  2021-06-24       Impact factor: 2.370

8.  Iron excess disturbs metabolic status and relative gonad mass in rats on high fat, fructose, and salt diets.

Authors:  Joanna Suliburska; Paweł Bogdański; Monika Szulińska
Journal:  Biol Trace Elem Res       Date:  2012-11-22       Impact factor: 3.738

9.  Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major.

Authors:  Ola Galal Behairy; Eman Rateb Abd Almonaem; Neveen Tawfik Abed; Omima M Abdel Haiea; Rasha M Zakaria; Rania I AbdEllaty; Effat H Asr; Amira Ibrahim Mansour; Amira Mn Abdelrahman; Hoda A Elhady
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-09-11

10.  IgA nephropathy associated with thalassemia: a case report.

Authors:  Jun Ni; Caifeng Zhu; Xiaoqiu Ni; Jiazhen Yin
Journal:  BMC Nephrol       Date:  2020-05-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.